Your browser doesn't support javascript.
loading
Youth's Perceptions of E-cigarette Advertisements with Cessation Claims.
Kim, Minji; Ling, Pamela M; Ramamurthi, Divya; Halpern-Felsher, Bonnie.
Afiliación
  • Kim M; Postdoctoral Fellow, University of California, San Francisco, Center for Tobacco Control Research and Education, San Francisco, CA.
  • Ling PM; Professor, University of California, San Francisco, Center for Tobacco Control Research and Education, San Francisco, CA.
  • Ramamurthi D; Research Associate, Stanford University, Stanford Research Into the Impact of Tobacco Advertising, Palo Alto, CA.
  • Halpern-Felsher B; Professor, Stanford University, Department of Pediatrics, Palo Alto, CA.
Tob Regul Sci ; 5(2): 94-104, 2019 Mar.
Article en En | MEDLINE | ID: mdl-31840040
OBJECTIVES: E-cigarettes are not FDA-approved smoking cessation aids. Nevertheless, content analyses have shown that e-cigarette companies make claims about cessation efficacy. Some advertisements are explicit (directly mentioning their product can help smokers quit or stop smoking), while others are implicit (not containing cessation-related language, but implying cessation efficacy through subtle wording and imagery). This is the first study to examine directly how adolescents and young adults (AYAs) perceived these ads, and specifically whether they identify the cessation claims in e-cigarette advertisements. METHODS: 248 AYAs in California viewed 4 e-cigarette advertisements with cessation claims, then selected claims made by each advertisement. Descriptive statistics and multi-level logistic regression models were used to examine the relationship between the type of claims and perception. RESULTS: The claim "helps me quit smoking" was most frequently selected after viewing advertisements with explicit cessation claims, but not after viewing implicit claims. No significant effect of tobacco use and age on claim selection was observed. CONCLUSIONS: E-cigarette manufacturers make claims about cessation efficacy, and AYAs can identify such claims in advertisements, especially the explicit ones. FDA should regulate these advertisements as making therapeutic claims.
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: Tob Regul Sci Año: 2019 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: Tob Regul Sci Año: 2019 Tipo del documento: Article